DarioHealth Corp. (NASDAQ:DRIO) is reporting second quarter financial results on Tuesday 13th August 2019, before market open.
According to analysts surveyed by Thomson Reuters, DRIO is expected to report 2Q19 loss of $ 0.13 per share from revenue of $ 2.45 million.
For the full year, analysts anticipate top line of $ 10.30 million, while looking forward to loss of $ 0.5 per share bottom line.
Historical Earnings Performance
4Q17 results below analysts expectation by 320 percent, the report represented loss of $ 1.26 per share from the reveues of $ 2.06 million, analysts expected loss of $ 0.3 per share
1Q18 results surrendered to analysts view by 5.26 percent, the report depicted loss of $ 0.2 per share from the topline of $ 1.88 million, analysts forecasted loss of $ 0.19 per share
4Q18 results rose above street view by 26.67 percent, the report outlined loss of $ 0.11 per share from the reveues of $ 1.70 million, analysts predicted loss of $ 0.15 per share
1Q19 results surrendered to market expectation by 15.38 percent, the report interpreted loss of $ 0.15 per share from the topline of $ 2.24 million, analysts anticipated loss of $ 0.13 per share
Recent Analyst recommendations
On 6th June 2019, initiated by Craig Hallum at Buy rating, with $ 1.50 target price.